Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Pfizer acquires pharmaceutical company AstraZeneca

Pharmaceutical giant Pfizer will soon acquire AstraZeneca, a pharmaceutical and biologics company in London, as it expands its Essential Health portfolio.

Creative Medical Technology Holdings developing ovary regeneration technology

Creative Medical Technology has filed a patent application for a type of stem cell technology that can regenerate failing ovaries, a method that can help women suffering from premature ovarian failure.

Nathan Adelson Hospice to acquire Las Vegas Solari Hospice Care

Nevada-based Nathan Adelson Hospice has signed an agreement to acquire Las Vegas Solari Hospice Care in Southern Nevada, a deal that is expected to close by Sept. 7.

CMS lists what hospitals were paid under $1.5 billion Medicare appeals settlement

More than 2,000 U.S. hospitals received part of a $1.5 billion settlement from CMS in 2015 to resolve more than 346,000 disputed Medicare claims, and two years after offering the deal, the agency is revealing which hospitals were paid the most.

Feminine hygiene market expected to grow to $35.2 billion by 2024

As the usage of feminine hygiene products continues to increase worldwide, researchers are making predictions on how much money the increase could spawn.

Are non-profit hospital exec business relationships inherently unethical?

Non-profit hospital executives and administrators are up to 39 percent more likely to have business relationships with the hospitals they work for than employees of other types of non-profit organizations, according to a Wall Street Journal anlysis. 

Thumbnail

Pfizer to buy cancer drug maker Medivation for $14 billion

Pharmaceutical giant Pfizer has announced a new merger agreement with cancer drug company Medivation in a $14 billion deal that would add the expensive prostate cancer drug Xtandi to its portfolio.

PlatformQ Health and Global Genes partner to form the Google of rare diseases

Global Genes and PlatformQ Health are patterning up to develop the Google of rare disease, RareUniversity.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.